走進諾和諾德 更多 >>
諾和諾德是一家致力于人類健康、以先進的生物技術造福患者、醫生和社會的世界領先生物制藥公司。
諾和諾德公司的歷史最早可追溯至1923年，80多年來一直是世界糖尿病研究和藥物開發領域的主導。諾和諾德總部位于丹麥首都哥本哈根，現在全球79個國家設有分支機構，6個國家設有生產廠，截至08年底，員工超過 27，000名，銷售遍及180個國家。
諾和諾德憑借自身的研發實力成為世界糖尿病治療領域先導，在行業內擁有最為廣泛的糖尿病治療產品，其中包括最先進的胰島素給藥系統產品。
?
土耳其Erciyes大學內分泌系顧問Fahrettin Kelestimur教授
發布日期：2009-12-22 18:26 文章來源：丁香園
分享到： 收藏夾 新浪微博 騰訊微博 開心網 豆瓣社區 人人網
關鍵詞： 諾和銳
諾和諾德
novonordisk
Fahrettin
Kelestimur
糖尿病
胰島素
點擊次數：
?
Fahrettin Kelestimur
Kayseri, Turkey
Fahrettin Kelestimur is currently a consultant in the Department of Endocrinology at the School of Medicine of Erciyes University.
He was an Executive Committee member of the European Neuroendocrine Association (ENEA) and a member of the Executive Committee of European Society of Endocrinology (ESE). He is the former President of the Society of Endocrinology and Metabolism of Turkey (SEMT). He is also a member of various Study Groups.
Professor Kelestimur is a member of the Editorial Board of Growth Hormone and IGF Research and Expert Review in Endocrinology and Metabolism. He is the Associate Editor of Experimental and Clinical Endocrinology and Diabetes and a member of the
Advisory Board of the Journal of Endocrinological Investigation. His interests are neuroendocrinology, diabetes mellitus, reproductive endocrinology and pituitary medicine and is the author of over 152 peer-reviewed scientific articles.
編輯: xiaoyan 作者:丁香園通訊員
以下網友留言只代表網友個人觀點，不代表網站觀點
